ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Genzyme Sells Unit, Cuts 1,000 Jobs

by Ann M. Thayer
September 20, 2010 | APPEARED IN VOLUME 88, ISSUE 38

Genzyme has agreed to sell its Genzyme Genetics testing services business, which had revenues of $370 million in 2009, to Laboratory Corporation of America for $925 million. The sale is part of a five-year plan that Genzyme announced in May to find alternatives for three noncore units. It is trying to strengthen its business in the face of near-devastating manufacturing problems and after rejecting a takeover offer from Sanofi-Aventis. In addition to the sale, Genzyme will also cut 1,000 jobs over 15 months to reduce operating costs.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment